46577 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 09
18:58 UTC
|
TTAN
ServiceTitan
|
◎ Target | David Hynes ★★★★☆ #645 | Buy | $105.00→ $90.00-14.3% |
|
Sep 09
18:58 UTC
|
STLD
Steel Dynamics
|
◎ Target | Bennett Moore ★★☆☆☆ #2299 | Neutral | $260.00→ $273.00+5.0% |
|
Sep 09
18:58 UTC
|
SLB
SLB
|
◎ Target | Josh Silverstein ★★☆☆☆ #2447 | Buy | $66.00→ $72.00+9.1% |
|
Sep 09
18:58 UTC
|
SEI
Solaris Energy Infrastructure
|
◎ Target | J.R. Weston not yet tracked | Outperform | $82.00→ $96.00+17.1% |
|
Sep 09
18:58 UTC
|
RS
Reliance
|
◎ Target | Bennett Moore ★★☆☆☆ #2299 | Neutral | $398.00→ $390.00-2.0% |
|
Sep 09
18:58 UTC
|
RGEN
Repligen
|
◎ Target | Dan Leonard ★★★★☆ #383 | Buy | $195.00→ $225.00+15.4% |
|
Sep 09
18:58 UTC
|
POR
Portland General Electric
|
◎ Target | Aidan Kelly ★★★☆☆ #1924 | Neutral | $56.00→ $53.00-5.4% |
|
Sep 09
18:58 UTC
|
PLCE
Children's Place
|
◎ Target | Jay Sole ★★★☆☆ #2211 | Neutral | $4.00→ $3.25-18.8% |
|
Sep 09
18:58 UTC
|
PHVS
Pharvaris
|
◎ Target | Maxwell Skor ★★☆☆☆ #2838 | Overweight | $46.00→ $62.00+34.8% |
|
Sep 09
18:58 UTC
|
PDM
Piedmont Realty Trust
|
◎ Target | Anthony Paolone ★★★☆☆ #1018 | Neutral | $10.00→ $11.00+10.0% |
|
Sep 09
18:58 UTC
|
ORA
Ormat Technologies
|
◎ Target | Mark Strouse ★★☆☆☆ #2656 | Neutral | $122.00→ $131.00+7.4% |
|
Sep 09
18:58 UTC
|
OKE
ONEOK
|
◎ Target | Robert Kad ★★★☆☆ #1998 | Equal Weight | $105.00→ $112.00+6.7% |
|
Sep 09
18:58 UTC
|
OGE
OGE Energy
|
◎ Target | Aidan Kelly ★★★☆☆ #1924 | Overweight | $55.00→ $54.00-1.8% |
|
Sep 09
18:58 UTC
|
NWE
NorthWestern
|
◎ Target | Aidan Kelly ★★★☆☆ #1924 | Neutral | $76.00→ $73.00-3.9% |
|
Sep 09
18:58 UTC
|
NUE
Nucor
|
◎ Target | Bennett Moore ★★☆☆☆ #2299 | Overweight | $294.00→ $308.00+4.8% |
|
Sep 09
18:58 UTC
|
NTRA
Natera
|
◎ Target | Doug Schenkel not yet tracked | Buy | $290.00→ $435.00+50.0% |
|
Sep 09
18:58 UTC
|
MRVI
Maravai LifeSciences
|
◎ Target | Dan Brennan not yet tracked | Neutral | $2.50→ $8.00+220.0% |
|
Sep 09
18:58 UTC
|
LULU
lululemon athletica
|
◎ Target | Paul Lejuez ★★★☆☆ #1049 | Neutral | $130.00→ $117.00-10.0% |
|
Sep 09
18:58 UTC
|
LFST
LifeStance Health Group
|
◎ Target | Richard Close ★★★☆☆ #1303 | Buy | $13.00→ $15.00+15.4% |
|
Sep 09
18:58 UTC
|
IVN
Ivanhoe Mines
|
◎ Target | firm only | Sec→ r Perform | C$13.00→ C$13.50+3.8% |
|
Sep 09
18:58 UTC
|
IVN
Ivanhoe Mines
|
◎ Target | firm only | Buy | C$13.00→ C$15.00+15.4% |
|
Sep 09
18:58 UTC
|
IVN
Ivanhoe Mines
|
◎ Target | firm only | Buy | C$15.00→ C$17.00+13.3% |
|
Sep 09
18:58 UTC
|
GH
Guardant Health
|
◎ Target | Dan Leonard ★★★★☆ #383 | Buy | $175.00→ $225.00+28.6% |
|
Sep 09
18:58 UTC
|
EXE
Expand Energy
|
◎ Target | John Freeman ★★★★☆ #860 | Strong-Buy | $145.00→ $147.00+1.4% |
|
Sep 09
18:58 UTC
|
EPR
EPR Properties
|
◎ Target | Anthony Paolone ★★★☆☆ #1018 | Overweight | $62.00→ $65.00+4.8% |
|
Sep 09
18:58 UTC
|
DEI
Douglas Emmett
|
◎ Target | Anthony Paolone ★★★☆☆ #1018 | Neutral | $15.00→ $16.00+6.7% |
|
Sep 09
18:58 UTC
|
CMC
Commercial Metals
|
◎ Target | Bennett Moore ★★☆☆☆ #2299 | Overweight | $86.00→ $83.00-3.5% |
|
Sep 09
18:58 UTC
|
CLF
Cleveland-Cliffs
|
◎ Target | Bennett Moore ★★☆☆☆ #2299 | Neutral | $11.00→ $13.00+18.2% |
|
Sep 09
18:58 UTC
|
BRZE
Braze
|
◎ Target | Alexei Gogolev ★★★☆☆ #977 | Overweight | $35.00→ $34.00-2.9% |
|
Sep 09
18:58 UTC
|
BRZE
Braze
|
◎ Target | Taylor McGinnis ★★★★★ #278 | Buy | $28.00→ $32.00+14.3% |
|
Sep 09
18:58 UTC
|
BRZE
Braze
|
◎ Target | Brian Peterson ★★★★☆ #417 | Outperform | $27.00→ $33.00+22.2% |
|
Sep 09
18:58 UTC
|
BRZE
Braze
|
◎ Target | David Hynes ★★★★☆ #645 | Buy | $35.00→ $37.00+5.7% |
|
Sep 09
18:58 UTC
|
BBOT
BridgeBio Oncology Therapeutics
|
◎ Target | Sean McCutcheon ★★★★★ #177 | Outperform | $24.00→ $22.00-8.3% |
|
Sep 09
18:58 UTC
|
BBOT
BridgeBio Oncology Therapeutics
|
◎ Target | John Newman ★☆☆☆☆ #2991 | Buy | $23.00→ $20.00-13.0% |
|
Sep 09
18:58 UTC
|
TLTZY
Tele2
|
↓ Downgrade | firm only | Outperform→ Neutral | |
|
Sep 09
18:58 UTC
|
TEF
Telefonica
|
↑ Upgrade | firm only | Neutral | |
|
Sep 09
17:58 UTC
|
UCB
United Community Banks
|
◎ Target | Stephen Scouten ★★★★☆ #880 | Neutral | $37.00→ $38.00+2.7% |
|
Sep 09
17:58 UTC
|
GEMI
Gemini Space Station
|
◎ Target | James Yaro ★★☆☆☆ #2427 | Sell | $3.50→ $4.00+14.3% |
|
Sep 09
17:58 UTC
|
ETOR
eToro Group
|
◎ Target | James Yaro ★★☆☆☆ #2427 | Neutral | $32.00→ $36.00+12.5% |
|
Sep 09
17:58 UTC
|
DYN
Dyne Therapeutics
|
◎ Target | Michael Ulz ★☆☆☆☆ #3065 | Overweight | $45.00→ $36.00-20.0% |
|
Sep 09
17:58 UTC
|
COIN
Coinbase Global
|
◎ Target | James Yaro ★★☆☆☆ #2427 | Buy | $196.00→ $219.00+11.7% |
|
Sep 09
17:58 UTC
|
CHYM
Chime Financial
|
◎ Target | Timothy Chiodo ★★★★☆ #800 | Neutral | $28.00→ $31.00+10.7% |
|
Sep 09
17:58 UTC
|
CHYM
Chime Financial
|
◎ Target | James Faucette ★★★☆☆ #1746 | Overweight | $39.00→ $40.00+2.6% |
|
Sep 09
17:58 UTC
|
CHYM
Chime Financial
|
◎ Target | Patrick Moley ★★★☆☆ #1302 | Overweight | $35.00→ $40.00+14.3% |
|
Sep 09
17:58 UTC
|
ABM
ABM Industries
|
◎ Target | Joshua Chan ★★★☆☆ #1300 | Neutral | $45.00→ $51.50+14.4% |
|
Sep 09
16:58 UTC
|
PHVS
Pharvaris
|
◎ Target | Joseph Schwartz ★★★★☆ #595 | Outperform | $50.00→ $65.00+30.0% |
|
Sep 09
16:58 UTC
|
MRK
Merck & Co., Inc.
|
◎ Target | Daina Graybosch ★★★★☆ #515 | Outperform | $127.00→ $161.00+26.8% |
|
Sep 09
16:58 UTC
|
EVMN
Evommune
|
◎ Target | Thomas Smith ★★★★☆ #529 | Outperform | $28.00→ $22.00-21.4% |
|
Sep 09
16:58 UTC
|
BXP
BXP
|
◎ Target | Michael Lewis ★★★☆☆ #1234 | Hold | $64.00→ $68.00+6.2% |
|
Sep 09
15:58 UTC
|
TTAN
ServiceTitan
|
◎ Target | Parker Lane not yet tracked | Buy | $125.00→ $100.00-20.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.